Archives
-
Nav1.5 Ser571 Links Aging to Cardiac Dysfunction
2026-09-13
The reference study identifies Nav1.5 Ser571 phosphorylation and increased late sodium current as an early mechanistic link between aging, delayed ventricular repolarization, and impaired diastolic relaxation. Its combination of age-stratified mouse models, bidirectional genetic manipulation, electrophysiology, calcium imaging, and myocyte mechanics provides a framework for testing late sodium current inhibition in cardiac aging research.
-
RepSox for iPSC Platelet Research
2026-09-12
RepSox provides a precise way to interrogate ALK5-dependent TGF-β signaling in reprogramming and differentiation experiments. This practical guide connects its established Sox2-replacement activity with a 2026 hiPSC-to-platelet workflow while clearly separating validated evidence from testable applications.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-09-11
A 2026 FASEB Journal study developed chemically modified p21 mRNA-loaded lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links restoration of nuclear p21 to cell-cycle inhibition, DNA-damage accumulation, apoptosis, and tumor suppression in an orthotopic mouse model while highlighting the translational potential and remaining limitations of local mRNA delivery.
-
nor-Binaltorphimine Dihydrochloride in KOR Assays
2026-09-11
Learn how to use nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist in receptor signaling, pain-behavior, and brain-to-spinal circuit experiments. This practical guide covers stock preparation, assay controls, workflow design, troubleshooting, and translation of recent mouse findings into reproducible research strategies.
-
Single-Cell RNA Isoforms in Alzheimer’s Disease
2026-09-10
This study combines 10X Genomics single-nucleus profiling with PacBio Kinnex long-read sequencing to resolve full-length RNA isoforms in post-mortem Alzheimer’s disease and non-diseased brains. The findings reveal extensive cell-type-specific isoform diversity, disease-associated transcript switching, and candidate recombination-linked RNA structures that are obscured by conventional short-read sequencing.
-
Amorolfine Hydrochloride in Yeast Membrane Research
2026-09-10
Build a mechanistic yeast assay that connects membrane-synthesis stress with ploidy, cell size, and surface integrity. This workflow uses Amorolfine Hydrochloride as a defined antifungal reagent for orthogonal viability, membrane, DNA-content, and gene-expression measurements rather than relying on growth inhibition alone.
-
Toremifene in Prostate Cancer Assay Design
2026-09-09
Toremifene is a selective estrogen-receptor modulator for dissecting hormone-responsive prostate cancer biology. This article presents a layered assay strategy that separates estrogen receptor effects on growth from the STIM1–calcium signaling mechanisms associated with bone metastasis.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-09
Yin et al. identify a brain-to-spinal lPBN–PVH–spinal dorsal horn pathway that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study shows that central µ-opioid receptor activation can disrupt dorsal horn gating of mechanical pain, providing a circuit-level framework for opioid receptor signaling research and chronic pain models.
-
APS–miR-183-5p–Keap1–Nrf2 in Fish Cells
2026-09-08
A 2026 study identifies a miR-183-5p–Keap1–Nrf2 pathway through which Astragalus polysaccharides protect large yellow croaker head kidney cells from hydrogen peroxide-induced oxidative injury. Its combination of oxidative-stress, cell-death, antioxidant, and microRNA–target analyses provides a mechanistic framework for interpreting APS activity in fish cell models.
-
SP600125: Translating JNK Signals into Inflammation Insight
2026-09-08
A mechanistic and translational framework for using SP600125 to interrogate JNK-dependent cytokine signaling, with emphasis on the TLR2/TLR4–MyD88–MAPK axis activated by Chlamydia psittaci CPSIT_0844.
-
1-myristoylglycerophosphocholine Assay Workflows
2026-09-07
Build defined 14:0 Lyso-PC experiments for fibroblast activation, epithelial lipid transfer, and smooth muscle function. This workflow combines species-resolved lipidomics, concentration-response design, and practical handling controls to improve reproducibility across lipid signaling and fibrosis models.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-09-07
This study develops a hyaluronate-conjugated lipid nanoparticle that delivers PTEN mRNA through the skin and targets CD44-expressing melanoma cells. Its findings connect transient tumor suppressor restoration with immunogenic cell death, tumor growth inhibition, and local immune activation, while highlighting the formulation challenges that shape transdermal mRNA therapy.
-
Gramine–CUL3–MTDH Ferroptosis in TNBC
2026-09-05
A 2026 study identifies gramine as a selective inhibitor of triple-negative breast cancer and links its activity to a previously described CUL3–MTDH regulatory route that promotes ferroptosis. By combining chemical screening, target-engagement assays, genetic perturbation, and xenograft models, the work provides a mechanistic framework for evaluating gramine while leaving important translational questions unresolved.
-
DAMGO as a Circuit Tool in Opioid Pain Research
2026-09-04
DAMGO is a selective µ-opioid receptor agonist that connects receptor-proximal pharmacology with circuit-level studies of opioid-induced mechanical hypersensitivity. This article presents an assay framework for interpreting DAMGO across signaling, tissue, and chronic pain research models.
-
Cell Counting Kit-8 for Melanoma Cell Studies
2026-09-04
Use Cell Counting Kit-8 to quantify melanoma cell growth, treatment response, and viability without a solubilization step. This practical workflow translates HSPA4 melanoma research into controlled, plate-based experiments with clear optimization and troubleshooting guidance.